We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Delivers 483 After Sponsor Fails to Monitor Clinical Investigations
FDA Delivers 483 After Sponsor Fails to Monitor Clinical Investigations
The FDA delivered a Form 483 to a clinical trial director after an investigation revealed failures to monitor the study’s progress and to obtain required statements from investigators.